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    The most important problem with radiotherapy is the limitation of whole body irradiation of a metastatic 
patient. There are evidence showing that similar effect will occur in non-irradiated tumors similar to the 
irradiated ones. This effect is called abscopal effect. In the present study, the abscopal effect on local 
induced mice breast cancers has been investigated. One million of 4T1 mice breast cancer cell line was 
injected to balb/c mice subcutaneously while being under anesthesia. After the growth of tumors till 
becoming palpable, one of two induced tumors were exposed to total 28 Gy, with gamma rays emitted from 
a cobalt -60 tele-therapy machine in 14 fractions with 2 Gy daily doses. Tumor volumes were measured, 
using the caliper. The data was analyzed by the use of non-parametrical and ANOVA tests. Similar growth 
in non-irradiated control tumors was seen. After 10 or 11 fractions of one- side irradiation and total dose of 
20 to 22 Gy, however, non-irradiated tumors, similar to irradiated ones, showed similar effect, reduction of 
size and volume different from control groups (P<0.05).The reduction of non-irradiated tumors relative to 
irradiation of another tumor in the same mouse is the emblem of occurrence of the abscopal effect. The 
mechanism of the abscopal effect is unknown but it could be related to the release of cytokines from 
irradiated tumors with their receptors existing on the surface of non-irradiated tumors. By induction of this 
effect, the remission probability of small metastases after local irradiation could be possible. 
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INTRODUCTION 
Nowadays cancer is one of the main reasons of 
death in developing and developed countries [1]. 
Presently, three main modalities exist for 
management of cancer. Surgery is the first 
strategy of cure in low risk tumors and tumors 
with high chance of succeeding [2]. The goal of 
radiotherapy is to deliver the higher dose to tumor 
and lower to normal surrounding tissues [3]. To 
investigate the effect of each daily fraction of 
dose in radiotherapy, the dose-response and iso-
effect curves have been proposed [4]. According 
to the target idea and its effect on these curves, it 
had been considered that damage to cells merely 
occurs for cells in irradiation field. In other 
words, radiation should directly hit the cells [5]. 
This theory was obsolesced after Dr. Mole’s 
finding in 1953 that neighbor cells also show the 
similar effect, similar to genomic instability and 
chromosomal damages [6]. After this invention, 
the new era of radiobiology is emerging and 
researches have inclined toward finding of its 
mechanism. These effects had been called off-
 




target effects including bystander and abscopal 
effect [7]. The bystander effect is damages in near 
or close cells to irradiation field and the abscopal 
effect is the existence of similar effect in faraway 
cells [8]. Induction of off-target effects has been 
reported within both in-vitro cell culture and in-
vivo animals [8, 9]. There are several case reports 
that irradiation of main tumor causes remission of 
metastases [10-12]. Some studies done with high 
dose per fraction and / or fractions of irradiation 
proved to be successful  [13]. Other studies were 
done over the combination of drugs, such as anti-
CTLA with irradiation [14]. Similarly, they are 
interested in induction of the abscopal effect in 
bracy-therapy and along with radical and / or 
palliative goal [15]. Occurrence of abscopal effect 
is related to releasing cytokines, inflammatory 
factors or tumor necrosis factors [16-22]. 
According to these studies, induction of the 
abscopal effect alone, without the use of any drug 
are rare. So, if one could induce the abscopal 
effect without any drug, it could be a new 
regulatory arm in treatments. For the purpose of 
achieving that goal, a study similar to human 
conventional fractionation irradiation is needed. 
The aim of this study is to investigate the 
reciprocal influence of irradiation on a tumor and 
its effect on the non-irradiated one. 
 
MATERIALS AND METHODS 
The population of this experimental study were 
tumor bearing Balb/c mice. The sample size was 
determined by using the following formula:     
 
    
          
                
   
 
According to this formula, the sample size, with a 
95 % of confidence and significance value of 
p<0.05 was 10 mice but as the deaths of mice was 
a probability, 15 mice were chosen. During the 
experiment 5 mice died. This study was carried 
out with regard to the guidelines for animal 
experiments at the University of Tokyo and Iran 
Ministry of health. All the scarified mice by 
inhalation of CO2 gas and the dead mice were 
burnt with discards of hospital.  
Cell line 
The 4T1 cell line (ATCC number: CRL- 2539), 
(Triple-negative breast cancer adenocarcinoma) 
was bought from Shahid Beheshti University, 
Tehran, Iran. These cells were cultured in RPMI-
1640 culture medium (Gibco, Germany) including 
10% fetal bovine serum (Gibco, Germany), 
penicillin 100unit/ml and streptomycin 100 
mg/ml and stored in 5% co2incubator[26]. The 
subculture was done after reaching 80% 
confluence by the use of trypsin- EDTA 0.25% 
(Merck, Germany). 
Animals 
Male 4-6 week-old balb/c mice were provided 
from animal lab of Iranian Pasteur institute. Mice 
were caged in groups of 3-5, and fed with animal 
standard mouse pellet and water ad libitum [26, 
27]. Their backs and hind limbs were shaved. All 
of the mice were anesthetized in isoflurane 
chamber before all procedures (cell injection and 
irradiation) and were observed until fully 
recovered. Scarificing was done with lethal 
inhalation of carbon monoxide two days after the 
irradiation had finished. The tumor volume was 
calculated using the formula: tumor volume   =
(major axis) × (minor axis)
2
 × 0.5236[26, 27], and 
after that, by dividing the irradiated tumor volume 
by non-irradiated ones, ratios of different volumes 
achieved. All animal experiments were carried out 
with respect to the guidelines for animal 
experiments at the University of Tokyo. 
Tumor measurement 
In the flank region of mice, 4T1 cell line were 
injected (1×10
6
 cells) [27]. When tumors became 
palpable, the mice were randomized and 
irradiated on one side of the tumor while the other 
whole side of the body was shielded with lead. 
Randomization was performed at the day of 
implantation to eliminate any potential observer 
bias caused by randomization at a later time point. 
Both treatment and control groups had 5 mice. 
Both tumors in flank region were 4T1. Then, by 
means of a caliper which accuracy was 1mm, size 
of tumors were measured [26]. Irradiation was 
started in day 16 (needed days to grow the tumors 
to be palpable) and 28 Gy delivered in 14 
fractions (14×2Gy), (5 fractions per week), 
similar to conventional human radiotherapy 
course. The control groups received sham 
treatment by immobilization of mice through 
anesthetization on coach of cobalt-60. 
 




Tumor irradiation  
Irradiation was done with gamma rays generated 
from Co
60 
teletherapy machine ( Theratron 760-c, 
AECl Canada). The field size was 5×5 cm, in 80 
cm and SSD technique, each fraction 2 Gy and 5 
fractions per week for 14 fractions, with dose rate 
of 54 cGy / min [24]. During irradiation, all of the 
mice were anesthetized with isoflurane to avoid 
movement. 
Irradiation dose Calculation 
Tumor bearing mice were held in prone position 
and radiation delivered to the targeted tumor-side. 
The reference point for the prescription of dose 
was set as 0.5 cm depth (dm) from the skin. The 
irradiated field was determined using computer 
tomography-based simulation set to spare 
hematopoietic and critical organs. The absorbed 
dose into the dorsal spine was calculated to below 
10% [6]. 
Statistics  
SPSS 16.0 software was used for data analysis.   
The non-parametrical Mann- Whitney test was 
used to determine the significance of differences 
between variables. Mean and standard Errors 
were used to report the values of measured 
variables, with a 95 % of confidence (significance 
value of p<0.05 was considered). 
 
RESULTS  
After 14 2±  days, those mice with visible bulks of 
tumor were categorized randomly. Then, 
irradiation after day 16 was started according to 2 
Gy in 5 fractions at week. 
 
Table 1.Data of tumor volume measurement in some different days  (the days have been added up with initial 16 days needed for being palpable) 
Fraction of treatment After injection`s days measurement 
Mean ± SE 
Irradiated site Shielded site 
1st 17th 6.778 ± 0.1982 7.068 ±  0.1403 
7th 25th 1.074  ±  0.2524 1.045  ±  0.1351 
14th 33th 1.072  ±  0.3030 1.072  ±  0.1313 
 
All mice in the control groups, as seen in the 
figure 1, had continuous fluctuation in tumor 
volume ratios (p=0.002). The two stages of 
fluctuations were seen, before 8
th
 fraction with its  
unpredictable rate and after 8
th
 fraction with its 
continuous decline with fractionation (figure 1). 
 
 
Figure 1.Unstable and unpredictable trend of tumor growth in control group 
 
The rate of tumor volumes variation in the control 
groups were faster than that of the treatment ones 
(p=0.000).The tumor ratios were different in 
treatment group compared with the sham group. 
Also the behavior of curves between treatment 
and control groups were different. In the 
treatment groups, curves became flat after 
induction of abscopal effect (p=0.001). The dose 
level that was required for induction of abscopal 
effect is shown in figure 2. Based on our data 
analysis, 20 or 22Gy is needed for the abscopal 
effect to be observed (P = 0.000). Non-irradiated 
tumors in treatment groups showed similar 
variation to the exposed ones (figures 1 and 2).   
 
 





Figure 2.Illustrating the irradiated / non-irradiated ratio during 14 fractions of irradiation in treatment group 
 




Figure 3.Time table of all processes ofthe study from beginning of study till scarification. 
 
1- Injection of cell line into mice 
2- Onset of irradiation 
3- End of irradiation course 
4- Scarification Day 
 
DISCUSSION 
In this study we showed that with merely local 
radiotherapy, the induction of abscopal effect in 
mice bearing 4T1 cell line is achievable. 
Prevention of tumor growth which was observed 
with diverse mouse tumors [8], including LLC, 
Meth Afibro sarcoma, and Colon adenocarcinoma 
suggests that the induction of abs copal effect was 
irrelevant to a specific tumor type [29]. After 14 
fractions of 2Gy irradiation in 3 weeks, volume of 
tumors rather than increasing led to steady plateau 
phase (figures 2 and 3), which may suggest 
enough production of effective agent(s) to prevent 
more growth and /or less production to achieve 
remission. After 10 fractions of irradiation, the 
dose threshold to induction of steady level was 
seen which would be the indicator of dose 
dependency. When the same tumor, located in 
different site were irradiated, the similar trend of 
tumor growth in non-irradiated one became 
significant. Different and similar trend in control 
and non-irradiated groups were seen respectively, 
proving that abscopal effect in treatment group 
has occurred. Furthermore, when different bulks 
of tumors were irradiated, in order to investigate 
whether this effect depends on tumor size, all 
fluctuations in the treatment groups were 
resembled to previous exposed ones. To make the  
data more quantifying and feasible for 
comparison, this study’s datais indicated in terms 
of irradiated /non- irradiated ratio. This ratio 
obtained by the measured volumes for each tumor 
in irradiated site was divided by non-irradiated 
ones (figure2).   
 






Figure 4.Comparison of trends of volume growth in treatment and control groups. There is Plateau phase in treatment group while in 
control group the volume variations are more intensive.  
 
Although several different efforts in terms of 
inducing and enhancing of abscopal effect are in 
hand [23,24 and 28,29], induction of this effect 
without adding up the immune stimulatory factors 
[23, 28] or gene engineering [24] has not been 
previously investigated. The usage of clinical 
abscopal effect should include the induction 
probability and its magnitude in conventional 
irradiation scheme. Our data is the first document 
which serves as citable paper to future non- 
consecutively irradiation studies.  Existing data in 
fractionation style are methodically different with  
 
human clinical regimens, indicating that those 
data are far from being used in clinics [24, 28-30]. 
Employing the Patched1 mice model, Mancuso et 
al have shown that a single dose of 1, 2, 3 or 10 
Gy of x-rays in mice proposed a dose level for 
induction of abscopal effect [7]. The present  data 
suggest that the effect of fractionation dose led to 
growth inhibition in both tumors of treatment 
group. The mechanisms responsible for our 
findings compared with that single dose 
irradiation difference in their illustrated end 
points necessitates further investigation. 
CONCLUSION 
All in all, based on similar volume variation in 
un-irradiated tumors in treatment group, this study 
shows that systemic effect of irradiation (OFF-
TARGET effects) is achievable. Also, appearance 
of this effect with different sizes of tumor bulk is 
a good indicator of its irrelevancy. Regression of 
both tumors in irradiated group after 20-22 Gy 
indicates the existence of a 
threshold dose. Lesser growing speed of volume 
changes in treatment group, in comparison with 
sham one implies the effectiveness of abscopal 
influence on the reduction of tumor growth. 
Taken together, the results of this study pertains 
to our investigation of in vitro and in vivo 
procedures, all of which needed to declare that 
induction of abscopal effect is reproducible.   
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